Effects of frailty, geriatric syndromes, and comorbidity on mortality and quality of life in older adults with HIV.


Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
03 01 2023
Historique:
received: 09 10 2022
accepted: 27 12 2022
entrez: 3 1 2023
pubmed: 4 1 2023
medline: 6 1 2023
Statut: epublish

Résumé

To understand the effects of frailty, geriatric syndromes, and comorbidity on quality of life and mortality in older adults with HIV (OAWH). Cross-sectional study of the FUNCFRAIL multicenter cohort. The setting was outpatient HIV-Clinic. OAWH, 50 year or over were included. We recorded sociodemographic data, HIV infection-related data, comorbidity, frailty, geriatric syndromes (depression, cognitive impairment, falls and malnutrition), quality of life (QOL) and the estimated risk of all-cause 5-year mortality by VACS Index. Association of frailty with geriatric syndromes and comorbidity was evaluated using the Cochran-Mantel-Haenszel test. Seven hundred ninety six patients were included. 24.7% were women, mean age was 58.2 (6.3). 14.7% were 65 or over. 517 (65%) patients had ≥3 comorbidities, ≥ 1 geriatric syndrome and/or frailty. There were significant differences in the estimated risk of mortality [(frailty 10.8%) vs. (≥ 3 comorbidities 8.2%) vs. (≥ 1 geriatric syndrome 8.2%) vs. (nothing 6.2%); p = 0.01] and in the prevalence of fair or poor QOL [(frailty 71.7%) vs. (≥ 3 comorbidities 52%) vs. (≥ 1 geriatric syndrome 58.4%) vs. (nothing 51%); p = 0.01]. Cognitive impairment was significantly associated to mortality (8.7% vs. 6.2%; p = 0.02) and depression to poor QOL [76.5% vs. 50%; p = 0.01]. Frailty, geriatric syndromes, and comorbidity had negative effects on mortality and QOL, but frailty had the greatest negative effect out of the three factors. Our results should be a wake-up call to standardize the screening for frailty and geriatric syndromes in OAWH in the clinical practice. NCT03558438.

Sections du résumé

BACKGROUND
To understand the effects of frailty, geriatric syndromes, and comorbidity on quality of life and mortality in older adults with HIV (OAWH).
METHODS
Cross-sectional study of the FUNCFRAIL multicenter cohort. The setting was outpatient HIV-Clinic. OAWH, 50 year or over were included. We recorded sociodemographic data, HIV infection-related data, comorbidity, frailty, geriatric syndromes (depression, cognitive impairment, falls and malnutrition), quality of life (QOL) and the estimated risk of all-cause 5-year mortality by VACS Index. Association of frailty with geriatric syndromes and comorbidity was evaluated using the Cochran-Mantel-Haenszel test.
RESULTS
Seven hundred ninety six patients were included. 24.7% were women, mean age was 58.2 (6.3). 14.7% were 65 or over. 517 (65%) patients had ≥3 comorbidities, ≥ 1 geriatric syndrome and/or frailty. There were significant differences in the estimated risk of mortality [(frailty 10.8%) vs. (≥ 3 comorbidities 8.2%) vs. (≥ 1 geriatric syndrome 8.2%) vs. (nothing 6.2%); p = 0.01] and in the prevalence of fair or poor QOL [(frailty 71.7%) vs. (≥ 3 comorbidities 52%) vs. (≥ 1 geriatric syndrome 58.4%) vs. (nothing 51%); p = 0.01]. Cognitive impairment was significantly associated to mortality (8.7% vs. 6.2%; p = 0.02) and depression to poor QOL [76.5% vs. 50%; p = 0.01].
CONCLUSIONS
Frailty, geriatric syndromes, and comorbidity had negative effects on mortality and QOL, but frailty had the greatest negative effect out of the three factors. Our results should be a wake-up call to standardize the screening for frailty and geriatric syndromes in OAWH in the clinical practice.
TRIAL REGISTRATION
NCT03558438.

Identifiants

pubmed: 36597036
doi: 10.1186/s12877-022-03719-8
pii: 10.1186/s12877-022-03719-8
pmc: PMC9809005
doi:

Banques de données

ClinicalTrials.gov
['NCT03558438']

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4

Informations de copyright

© 2023. The Author(s).

Références

BMJ Open. 2020 Nov 3;10(11):e034872
pubmed: 33148721
Curr Opin HIV AIDS. 2021 May 1;16(3):133-140
pubmed: 33833208
AIDS Care. 2022 Aug;34(8):966-973
pubmed: 34668807
J Am Geriatr Soc. 2012 May;60(5):896-904
pubmed: 22568483
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
J Gerontol A Biol Sci Med Sci. 2015 Dec;70(12):1542-7
pubmed: 26386010
AIDS Care. 2022 Aug;34(8):957-965
pubmed: 34383600
J Gerontol A Biol Sci Med Sci. 2001 Jun;56(6):M366-72
pubmed: 11382797
J Frailty Aging. 2019;8(1):10-16
pubmed: 30734825
Nat Aging. 2021 Jan;1(1):36-46
pubmed: 34476409
AIDS. 2022 Mar 1;36(3):459-471
pubmed: 34750289
Am J Med. 2004 Feb 1;116(3):179-85
pubmed: 14749162
HIV Med. 2020 Nov;21(10):617-624
pubmed: 32885559
AIDS Res Hum Retroviruses. 2019 Nov/Dec;35(11-12):1074-1081
pubmed: 31373215
AIDS. 2020 Jul 1;34(8):1217-1225
pubmed: 32287069
Clin Neuropsychol. 2022 Feb;36(2):367-387
pubmed: 34429015
Medicine (Baltimore). 2022 Mar 18;101(11):
pubmed: 35356931
Age Ageing. 2022 May 1;51(5):
pubmed: 35511728
Open Forum Infect Dis. 2022 Apr 10;9(5):ofac129
pubmed: 35415198
Lancet Infect Dis. 2015 Jul;15(7):810-8
pubmed: 26070969
Age Ageing. 2017 May 1;46(3):522-526
pubmed: 28203694
BMC Med. 2016 Jun 22;14(1):94
pubmed: 27334606
Rev Esp Geriatr Gerontol. 2018 Mar - Apr;53(2):105-110
pubmed: 28601217
J Am Geriatr Soc. 2019 Sep;67(9):1913-1916
pubmed: 31241764
PLoS One. 2013 Dec 18;8(12):e81355
pubmed: 24367482
J Infect Dis. 2020 Aug 17;222(6):919-928
pubmed: 31956893
Eur Geriatr Med. 2019 Apr;10(2):183-188
pubmed: 34652749
HIV Med. 2022 Dec;23 Suppl 5:3-115
pubmed: 36504313
PLoS One. 2022 Mar 30;17(3):e0266191
pubmed: 35353855
BMC Geriatr. 2018 Apr 20;18(1):99
pubmed: 29678160
Dement Geriatr Cogn Disord. 2011;31(2):126-31
pubmed: 21282950
High Blood Press Cardiovasc Prev. 2022 Jul;29(4):393-400
pubmed: 35723847
Eur Geriatr Med. 2019 Apr;10(2):227-238
pubmed: 34652756
Clin Exp Pharmacol Physiol. 2017 Dec;44 Suppl 1:3-8
pubmed: 29178613
J Geriatr Psychiatry Neurol. 1991 Jul-Sep;4(3):173-8
pubmed: 1953971
J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):149-63
pubmed: 23187941
J Am Geriatr Soc. 2007 May;55(5):780-91
pubmed: 17493201
AIDS. 2017 Jun 19;31(10):1471-1481
pubmed: 28574965
J Acquir Immune Defic Syndr. 2020 Nov 1;85(3):372-378
pubmed: 32732769
Int J Geriatr Psychiatry. 2001 Aug;16(8):751-61
pubmed: 11536341
Qual Life Res. 2019 Aug;28(8):2041-2056
pubmed: 30875008
AIDS Behav. 2019 Dec;23(12):3482-3492
pubmed: 30820848
Sci Rep. 2021 Feb 12;11(1):3738
pubmed: 33580123
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
J Acquir Immune Defic Syndr. 2020 Mar 1;83(3):284-291
pubmed: 32032279
J Gen Intern Med. 2016 Jun;31(6):630-7
pubmed: 26902246
Hepatol Commun. 2022 Aug;6(8):2011-2021
pubmed: 35411570
J Gerontol A Biol Sci Med Sci. 2014 Jul;69(7):833-42
pubmed: 24158766

Auteurs

Fátima Brañas (F)

Geriatrics Department, Hospital Universitario Infanta Leonor, Fundación para la Investigación e Innovación Biomédica H.U Infanta Leonor y H.U. Sureste. Universidad Complutense, Madrid, Spain. fbranas@gmail.com.

Miguel Torralba (M)

Internal Medicine Department, Hospital Universitario de Guadalajara. Universidad de Alcalá, Guadalajara, Spain.

Antonio Antela (A)

Infectious Diseases Unit, Hospital Clínico Universitario de Santiago de Compostela, Universidad de Santiago de Compostela, Madrid, Spain.

Jorge Vergas (J)

Internal Medicine/ Infectious Diseases Department, Hospital Universitario Clínico San Carlos, Madrid, Spain.

Margarita Ramírez (M)

Infectious Diseases Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Pablo Ryan (P)

HIV Clinic. Hospital Universitario Infanta Leonor, Fundación para la Investigación e Innovación Biomédica H.U Infanta Leonor y H.U. Sureste. Universidad Complutense. CIBERINFEC, Madrid, Spain.

Fernando Dronda (F)

Infectious Diseases Department, Hospital Universitario Ramón y Cajal. IRYCIS. CIBERINFEC, Madrid, Spain.

María José Galindo (MJ)

Internal Medicine/ Infectious Diseases Department, Hospital Universitario Clínico de Valencia, Valencia, Spain.

Isabel Machuca (I)

Infectious Diseases Department, Hospital Universitario Reina Sofía, Córdoba, Spain.

María Jesús Bustinduy (MJ)

Infectious Diseases Department, Hospital de Donostia, San Sebastián, Spain.

Alfonso Cabello (A)

Infectious Diseases Department, Fundación Jiménez Díaz, Madrid, Spain.

María Luisa Montes (ML)

HIV Unit/Internal Medicine Department, Hospital Universitario La Paz. IdiPAZ, Madrid, Spain.

Matilde Sánchez-Conde (M)

Infectious Diseases Department, Hospital Universitario Ramón y Cajal. IRYCIS. CIBERINFEC, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH